Circulating Micro RNAs Expression in Egyptian Bronchial Asthma and COPD Patients - Trial NCT02719145
Access comprehensive clinical trial information for NCT02719145 through Pure Global AI's free database. This phase not specified trial is sponsored by Tanta University and is currently Completed. The study focuses on Asthma,COPD. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Tanta University
Timeline & Enrollment
N/A
Oct 01, 2015
Sep 01, 2016
Primary Outcome
miR-7, miR-20a, miR-21, miR-22, miR-145 and miR-155 in serum samples from control, asthma and COPD Egyptian subjects.
Summary
This cross sectional study will be carried out on 30 subjects who will be recruited from the
 outpatient clinic of Chest Department, Tanta University Hospital.
 
 They will be classified into 3 groups:
 
 Group I: It will include 10 healthy volunteer subjects. Group II: It will include 10
 asthmatic patients. Group III: It will include 10 COPD patients. miR-7, miR-20a, miR-21,
 miR-22, miR-145 and miR-155 will be measured in serum samples from all subjects
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT02719145
Non-Device Trial